46 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 35178811 | Effects of curcumin supplementation on metabolic parameters, inflammatory factors and obesity values in women with rheumatoid arthritis: A randomized, double-blind, placebo-controlled clinical trial. | 2022 Apr | 1 |
2 | 33137599 | Effects of curcumin supplementation on blood glucose, insulin resistance and androgens in patients with polycystic ovary syndrome: A randomized double-blind placebo-controlled clinical trial. | 2021 Jan | 2 |
3 | 33200488 | The effects of curcumin intake on wound healing and metabolic status in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial. | 2021 Apr | 3 |
4 | 33673739 | A systematic review of the antidepressant effects of curcumin: Beyond monoamines theory. | 2021 May | 1 |
5 | 33825246 | Impact of curcumin on fatty acid metabolism. | 2021 Sep | 1 |
6 | 33861440 | Therapeutic Effect of Curcumin in Women with Polycystic Ovary Syndrome Receiving Metformin: A Randomized Controlled Trial. | 2021 | 3 |
7 | 33887887 | [Research advances on the effects and mechanism of curcumin in promoting diabetic wound healing]. | 2021 Apr 20 | 1 |
8 | 33907673 | The positive effect of short-term nano-curcumin therapy on insulin resistance and serum levels of afamin in patients with metabolic syndrome. | 2021 Mar-Apr | 5 |
9 | 33946029 | Effect of eight-week curcumin supplementation with endurance training on glycemic indexes in middle age women with type 2 diabetes in Iran, A preliminary study. | 2021 May-Jun | 1 |
10 | 34331688 | Effect of Curcumin on Glycemic Control in Patients with Type 2 Diabetes: A Systematic Review of Randomized Clinical Trials. | 2021 | 1 |
11 | 34484389 | Efficacy and Safety of Curcumin Supplement on Improvement of Insulin Resistance in People with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. | 2021 | 2 |
12 | 30796508 | Effects of phytosomal curcumin on anthropometric parameters, insulin resistance, cortisolemia and non-alcoholic fatty liver disease indices: a double-blind, placebo-controlled clinical trial. | 2020 Mar | 2 |
13 | 31970343 | Signal-off electrochemiluminescence immunosensors based on the quenching effect between curcumin-conjugated Au nanoparticles encapsulated in ZIF-8 and CdS-decorated TiO2 nanobelts for insulin detection. | 2020 Mar 2 | 2 |
14 | 32464315 | Curcumin metabolites contribute to the effect of curcumin on ameliorating insulin sensitivity in high-glucose-induced insulin-resistant HepG2 cells. | 2020 Sep 15 | 5 |
15 | 32655024 | The Effects of Nano-curcumin on Metabolic Status in Patients With Diabetes on Hemodialysis, a Randomized, Double Blind, Placebo-controlled Trial. | 2020 Jul | 1 |
16 | 30641821 | The antidiabetic and antioxidant properties of some phenolic phytochemicals: A review study. | 2019 Jan - Feb | 1 |
17 | 30684965 | Curcumin and/or omega-3 polyunsaturated fatty acids supplementation reduces insulin resistance and blood lipids in individuals with high risk of type 2 diabetes: a randomised controlled trial. | 2019 Jan 26 | 2 |
18 | 30983042 | Efficacy and safety of Rhizoma curcumea longae with respect to improving the glucose metabolism of patients at risk for cardiovascular disease: a meta-analysis of randomised controlled trials. | 2019 Oct | 1 |
19 | 30987250 | The Influence of Curcumin on the Downregulation of MYC, Insulin and IGF-1 Receptors: A possible Mechanism Underlying the Anti-Growth and Anti-Migration in Chemoresistant Colorectal Cancer Cells. | 2019 Apr 3 | 5 |
20 | 31078267 | Curcumin upregulates the Nrf2 system by repressing inflammatory signaling-mediated Keap1 expression in insulin-resistant conditions. | 2019 Jun 30 | 1 |
21 | 31149032 | The effect of curcumin supplementation on anthropometric indices, insulin resistance and oxidative stress in patients with type 2 diabetes: a randomized, double-blind clinical trial. | 2019 | 1 |
22 | 31780025 | The effects of curcumin supplementation on glycemic status, lipid profile and hs-CRP levels in overweight/obese women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled clinical trial. | 2019 Dec | 1 |
23 | 31818040 | Effect of Curcumin on Growth Performance, Inflammation, Insulin level, and Lipid Metabolism in Weaned Piglets with IUGR. | 2019 Dec 9 | 3 |
24 | 29089337 | Curcumin and other dietary polyphenols: potential mechanisms of metabolic actions and therapy for diabetes and obesity. | 2018 Mar 1 | 1 |
25 | 29542686 | Curcumin and dietary polyphenol research: beyond drug discovery. | 2018 May | 1 |
26 | 29793316 | Curcumin suppresses JNK pathway to attenuate BPA-induced insulin resistance in LO2 cells. | 2018 Jan | 6 |
27 | 30156145 | The Effects of Curcumin on Glycemic Control and Lipid Profiles Among Patients with Metabolic Syndrome and Related Disorders: A Systematic Review and Metaanalysis of Randomized Controlled Trials. | 2018 | 2 |
28 | 30209353 | Curcumin alleviates postprandial glycaemic response in healthy subjects: A cross-over, randomized controlled study. | 2018 Sep 12 | 3 |
29 | 30250013 | Curcumin, Cardiometabolic Health and Dementia. | 2018 Sep 24 | 1 |
30 | 28063511 | Tiny molecule, big power: Multi-target approach for curcumin in diabetic cardiomyopathy. | 2017 Feb | 1 |
31 | 28300666 | Curcumin attenuates BPA-induced insulin resistance in HepG2 cells through suppression of JNK/p38 pathways. | 2017 Apr 15 | 6 |
32 | 28377722 | Curcumin Improves Palmitate-Induced Insulin Resistance in Human Umbilical Vein Endothelial Cells by Maintaining Proteostasis in Endoplasmic Reticulum. | 2017 | 4 |
33 | 28684236 | Development of insulin resistance through sprouting of inflammatory markers during hypoxia in 3T3-L1 adipocytes and amelioration with curcumin. | 2017 Oct 5 | 2 |
34 | 26905192 | The role of curcumin in streptozotocin-induced hepatic damage and the trans-differentiation of hepatic stellate cells. | 2016 Apr | 1 |
35 | 27110686 | Proteasome inhibitors, including curcumin, improve pancreatic β-cell function and insulin sensitivity in diabetic mice. | 2016 Apr 25 | 4 |
36 | 27220352 | Curcumin inhibits lipolysis via suppression of ER stress in adipose tissue and prevents hepatic insulin resistance. | 2016 Jul | 3 |
37 | 25765666 | Curcumin attenuates cardiomyocyte hypertrophy induced by high glucose and insulin via the PPARγ/Akt/NO signaling pathway. | 2015 May | 1 |
38 | 24640977 | Brain insulin resistance in Alzheimer's disease and its potential treatment with GLP-1 analogs. | 2014 | 1 |
39 | 22335582 | Curcumin molecular targets in obesity and obesity-related cancers. | 2012 Feb | 1 |
40 | 23087505 | Insulin catalyzes the curcumin-induced wound healing: an in vitro model for gingival repair. | 2012 Jul-Aug | 1 |
41 | 21442412 | New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases. | 2011 Apr | 1 |
42 | 22024084 | Curcumin attenuates insulin resistance in hepatocytes by inducing Nrf2 nuclear translocation. | 2011 Nov-Dec | 5 |
43 | 20379410 | Role of insulin as a growth promoter in regulating the response of curcumin in human primary gingival fibroblasts: An in vitro study. | 2009 Sep | 2 |
44 | 18940397 | Beneficial effects of curcumin on hyperlipidemia and insulin resistance in high-fat-fed hamsters. | 2008 Nov | 1 |
45 | 19079906 | Therapeutic potential of curcumin in non-alcoholic steatohepatitis. | 2005 Dec | 1 |
46 | 12446602 | Requirement for PIKfyve enzymatic activity in acute and long-term insulin cellular effects. | 2002 Dec | 1 |